B-vitaminen en longkanker
Tweesnijdend zwaard
Grootschalige interventiestudies rond B-vitaminen maken zelden hun verwachtingen waar. Integendeel, ze laten soms ongewenste effecten van suppletie zien. De relatie tussen vitamine B6 en longkanker wordt nu intens onderzocht en ook worden er vraagtekens geplaatst bij foliumzuur en vitamine B12. Verliezen deze supplementen hun vanzelfsprekende imago ‘baat het niet, schaadt het niet’?
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
- Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009; 302(19):2119-26.
- Brasky TM, White E, Chen CL. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol. 2017; 35(30):3440-3448.
- Brasky TM, Ray RM, Navarro SL, et al. Supplemental one-carbon metabolism related B vitamins and lung cancer risk in the Women's Health Initiative. Int J Cancer. 2020; 147(5):1374-1384.
- Qin X, Cui Y, Shen L, et al. Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trials. Int J Cancer. 2013;133(5):1033–1041.
- Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. 2013 Mar 23;381(9871):1029-36.
- Pieroth R, Paver S, Day S, et al. Folate and Its Impact on Cancer Risk. Curr Nutr Rep. 2018;7(3):70‐84.
- Stanisławska-Sachadyn A, Borzyszkowska J, Krzemiński M, et al. Folate/homocysteine metabolism and lung cancer risk among smokers. PLoS One. 2019;14(4):e0214462.
- Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, et al. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial. Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):275-282.
- Pieroth R, Paver S, Day S, et al. C. Folate and Its Impact on Cancer Risk. Curr Nutr Rep. 2018; 7(3):70-84.
- Zeng J, Wang K, Ye F, et al. Folate intake and the risk of breast cancer: an up-to-date meta-analysis of prospective studies. Eur J Clin Nutr. 2019;73(12):1657‐1660.
- Mocellin S, Briarava M, Pilati P. Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. J Natl Cancer Inst. 2017; 109(3):1-9.
- Ueland PM, McCann A, Midttun Ø, et al. Inflammation, vitamin B6 and related pathways. Mol Aspects Med. 2017; 53:10-27.
- Ulvik A, Midttun Ø, Pedersen ER, et al. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. Am J Clin Nutr. 2012; 95(5):1072-8.
- Zuo H, Ueland PM, Eussen SJ, et al. Markers of vitamin B6 status and metabolism as predictors of incident cancer: the Hordaland Health Study. Int J Cancer. 2015; 136(12):2932-9.
- Zuo H, Ueland PM, Midttun Ø, et al. Results from the European Prospective Investigation into Cancer and Nutrition Link Vitamin B6 Catabolism and Lung Cancer Risk. Cancer Res. 2018; 78(1):302-308.
- Zuo H, Ueland PM, Midttun Ø, et al. Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Ann Oncol. 2019; 30(3):478-485.
- Obeid R, Geisel J, Nix WA. 4-Pyridoxic Acid/Pyridoxine Ratio in Patients with Type 2 Diabetes is Related to Global Cardiovascular Risk Scores. Diagnostics (Basel). 2019; 9(1).
- Zuo H, Tell GS, Ueland PM, et al. The PAr index, an indicator reflecting altered vitamin B-6 homeostasis, is associated with long-term risk of stroke in the general population: the Hordaland Health Study (HUSK). Am J Clin Nutr. 2018;107(1):105‐112.
- Fanidi A, Carreras-Torres R, Larose TL, et al. Is high vitamin B12 status a cause of lung cancer? Int J Cancer. 2019; 145(6):1499-1503.
- Arendt JFH, Sørensen HT, Horsfall LJ, et al. Elevated Vitamin B12 Levels and Cancer Risk in UK Primary Care: A THIN Database Cohort Study. Cancer Epidemiol Biomarkers Prev. 2019;28(4):814‐821.
- Houghton SC, Eliassen AH, Zhang SM, et al. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women. Breast Cancer Res Treat. 2019;176(1):191‐203.
- Ryg J, Nybo M, Hallas J. Cancer incidence in persons with elevated cobalamin levels. Eur J Clin Invest. 2013;43(6):557‐561.
- Arendt JF, Farkas DK, Pedersen L, et al. Elevated plasma vitamin B12 levels and cancer prognosis: A population-based cohort study. Cancer Epidemiol. 2016;40:158‐165.
- Huang JY, Larose TL, Luu HN, et al. Circulating markers of cellular immune activation in prediagnostic human serum in relation to lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Cancer. 2020;146(9):2394-2405.
- Pieroth R, Paver S, Day S, et al. Folate and Its Impact on Cancer Risk. Curr Nutr Rep. 2018;7(3):70‐84.
- Bensky MJ, Ayalon-Dangur I, Ayalon-Dangur R, et al. Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency. Drug Deliv Transl Res. 2019;9(3):625‐630.
- Moazzen S, Dolatkhah R, Tabrizi JS, et al. Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis. Clin Nutr. 2018;37(6 Pt A):1926‐1934.
- Song Y, Manson JE, Lee IM, et al. Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma. J Natl Cancer Inst. 2012 Oct 17;104(20):1562-75.
- Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006 Apr 13;354(15):1567-77
